|
1
|
Casadevall A and Pirofski LA: Virulence
factors and their mechanisms of action: The view from a
damage-response framework. J Water Health. 7 (Suppl 1):S2–S18.
2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Méthot PO and Alizon S: What is a
pathogen? Toward a process view of host-parasite interactions.
Virulence. 5:775–785. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cherubin P, Quiñones B and Teter K:
Cellular recovery from exposure to sub-optimal concentrations of AB
toxins that inhibit protein synthesis. Sci Rep.
8(2494)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Song J: Bacterial AB toxins and
host-microbe interactions. Adv Microb Physiol. 81:67–109.
2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ong HS and Yim HCH: Microbial factors in
inflammatory diseases and cancers. Adv Exp Med Biol. 1024:153–174.
2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Aggarwal N, Kitano S, Puah GRY, Kittelmann
S, Hwang IY and Chang MW: Microbiome and human health: Current
understanding, engineering, and enabling technologies. Chem Rev.
123:31–72. 2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dzutsev A, Badger JH, Perez-Chanona E, Roy
S, Salcedo R, Smith CK and Trinchieri G: Microbes and Cancer. Annu
Rev Immunol. 35:199–228. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
El Tekle G, Andreeva N and Garrett WS: The
role of the microbiome in the etiopathogenesis of colon cancer.
Annu Rev Physiol. 86:453–478. 2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sepich-Poore GD, Zitvogel L, Straussman R,
Hasty J, Wargo JA and Knight R: The microbiome and human cancer.
Science. 371(eabc4552)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hanahan D: Hallmarks of cancer: New
dimensions. Cancer Discov. 12:31–46. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Di Martino P: Bacterial adherence: Much
more than a bond. AIMS Microbiol. 4:563–566. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pizarro-Cerdá J and Cossart P: Bacterial
adhesion and entry into host cells. Cell. 124:715–727.
2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Fardini Y, Wang X, Témoin S, Nithianantham
S, Lee D, Shoham M and Han YW: Fusobacterium nucleatum adhesin FadA
binds vascular-endothelial cadherin and alters endothelial
integrity. Mol Microbiol. 82:1468–1480. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rubinstein MR, Wang X, Liu W, Hao Y, Cai G
and Han YW: Fusobacterium nucleatum promotes colorectal
carcinogenesis by modulating E-cadherin/β-catenin signaling via its
FadA adhesin. Cell Host Microbe. 14:195–206. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Guo P, Tian Z, Kong X, Yang L, Shan X,
Dong B, Ding X, Jing X, Jiang C, Jiang N and Yu Y: FadA promotes
DNA damage and progression of Fusobacterium nucleatum-induced
colorectal cancer through up-regulation of chk2. J Exp Clin Cancer
Res CR. 39(202)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Dadgar-Zankbar L, Elahi Z, Shariati A,
Khaledi A, Razavi S and Khoshbayan A: Exploring the role of
Fusobacterium nucleatum in colorectal cancer: Implications for
tumor proliferation and chemoresistance. Cell Commun Signal.
22(547)2024.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Rezasoltani S, Shams E, Piroozkhah M, Aidi
Y, Azizmohammad Looha M, Bagheri P, Behzadi Andouhjerdi R, Sadeghi
A, Rejali L and Nazemalhosseini-Mojarad E: FadA antigen of
Fusobacterium nucleatum: implications for ceRNA network in
colorectal cancer and adenomatous polyps progression. Discov Oncol.
16(58)2025.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gur C, Ibrahim Y, Isaacson B, Yamin R,
Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N,
Coppenhagen-Glazer S, et al: Binding of the Fap2 protein of
fusobacterium nucleatum to human inhibitory receptor TIGIT protects
tumors from immune cell attack. Immunity. 42:344–355.
2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Abed J, Emgård JE, Zamir G, Faroja M,
Almogy G, Grenov A, Sol A, Naor R, Pikarsky E, Atlan KA, et al:
Fap2 mediates fusobacterium nucleatum colorectal adenocarcinoma
enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host
Microbe. 20:215–225. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Parhi L, Alon-Maimon T, Sol A, Nejman D,
Shhadeh A, Fainsod-Levi T, Yajuk O, Isaacson B, Abed J, Maalouf N,
et al: Breast cancer colonization by Fusobacterium nucleatum
accelerates tumor growth and metastatic progression. Nat Commun.
11(3259)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Rad R, Gerhard M, Lang R, Schöniger M,
Rösch T, Schepp W, Becker I, Wagner H and Prinz C: The Helicobacter
pylori blood group antigen-binding adhesin facilitates bacterial
colonization and augments a nonspecific immune response. J Immunol.
168:3033–3041. 2002.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ohno T, Vallström A, Rugge M, Ota H,
Graham DY, Arnqvist A and Yamaoka Y: Effects of blood group
antigen-binding adhesin expression during helicobacter pylori
infection of mongolian gerbils. J Infect Dis. 203:726–735.
2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ong LL and Lin CH: Adhesion, infection,
and therapeutic treatment of Helicobacter pylori: A review on
current aspects and future promise. Discov Appl Sci.
6(323)2024.
|
|
26
|
Pasquereau-Kotula E, Martins M, Aymeric L
and Dramsi S: Significance of Streptococcus gallolyticus subsp.
gallolyticus association with colorectal cancer. Front Microbiol.
9(614)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Abdulamir AS, Hafidh RR and Abu Bakar F:
The association of Streptococcus bovis/gallolyticus with colorectal
tumors: The nature and the underlying mechanisms of its etiological
role. J Exp Clin Cancer Res. 30(11)2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chopra A, Bhat SG and Sivaraman K:
Porphyromonas gingivalis adopts intricate and unique molecular
mechanisms to survive and persist within the host: A critical
update. J Oral Microbiol. 12(1801090)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sheikh A and Fleckenstein JM: Interactions
of pathogenic Escherichia coli with CEACAMs. Front Immunol.
14(1120331)2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Nguyen D, Smolchek RA, Uruena JM, Sawyer
WG and Jobin C: 70274 TL1 team approach to investigating the
adhesin gene fimH in adherent invasive E. coli induced inflammation
and colorectal cancer development. J Clin Transl Sci. 5 (Suppl
1):S107–S108. 2021.
|
|
31
|
Ivleva EA and Grivennikov SI:
Microbiota-driven mechanisms at different stages of cancer
development. Neoplasia. 32(100829)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Sadeghi M, Mestivier D and Sobhani I:
Contribution of pks+ Escherichia coli (E. coli) to Colon
Carcinogenesis. Microorganisms. 12(1111)2024.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Guerra L, Cortes-Bratti X, Guidi R and
Frisan T: The biology of the cytolethal distending toxins. Toxins
(Basel). 3:172–190. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lai YR, Chang YF, Ma J, Chiu CH, Kuo ML
and Lai CH: From DNA damage to cancer progression: potential
effects of cytolethal distending toxin. Front Immunol.
12(760451)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ansari S and Yamaoka Y: Helicobacter
pylori virulence factor cytotoxin-associated gene A (CagA)-mediated
gastric pathogenicity. Int J Mol Sci. 21(7430)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Boncristiano M, Paccani SR, Barone S,
Ulivieri C, Patrussi L, Ilver D, Amedei A, D'Elios MM, Telford JL
and Baldari CT: The helicobacter pylori vacuolating toxin inhibits
T cell activation by two independent mechanisms. J Exp Med.
198:1887–1897. 2003.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Palframan SL, Kwok T and Gabriel K:
Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori
pathogenesis. Front Cell Infect Microbiol. 2(92)2012.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Suganuma M, Watanabe T, Sueoka E, Lim IK
and Fujiki H: Role of TNF-α-inducing protein secreted by
helicobacter pylori as a tumor promoter in gastric cancer and
emerging preventive strategies. Toxins (Basel).
13(181)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Fang Y, Yan C, Zhao Q, Xu J, Liu Z, Gao J,
Zhu H, Dai Z, Wang D and Tang D: The roles of microbial products in
the development of colorectal cancer: A review. Bioengineered.
12:720–735. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wu S, Rhee KJ, Albesiano E, Rabizadeh S,
Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, et al: A
human colonic commensal promotes colon tumorigenesis via activation
of T helper type 17 T cell responses. Nat Med. 15:1016–1022.
2009.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Patton MJ, McCorrister S, Grant C,
Westmacott G, Fariss R, Hu P, Zhao K, Blake M, Whitmire B, Yang C,
et al: Chlamydial protease-like activity factor and type III
secreted effectors cooperate in inhibition of p65 nuclear
translocation. mBio. 7:e01427–16. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Waguia Kontchou C, Gentle IE, Weber A,
Schoeniger A, Edlich F and Häcker G: Chlamydia trachomatis inhibits
apoptosis in infected cells by targeting the pro-apoptotic proteins
Bax and Bak. Cell Death Differ. 29:2046–2059. 2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Guo Y, Wang J, Zhou K, Lv J, Wang L, Gao
S, Keller ET, Zhang ZS, Wang Q and Yao Z: Cytotoxic necrotizing
factor 1 promotes bladder cancer angiogenesis through activating
RhoC. FASEB J. 34:7927–7940. 2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Travaglione S, Fabbri A and Fiorentini C:
The Rho-activating CNF1 toxin from pathogenic E. coli: A risk
factor for human cancer development? Infect Agent Cancer.
3(4)2008.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Radisky ES: Extracellular proteolysis in
cancer: Proteases, substrates, and mechanisms in tumor progression
and metastasis. J Biol Chem. 300(107347)2024.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Gnanasekaran J, Binder Gallimidi A, Saba
E, Pandi K, Eli Berchoer L, Hermano E, Angabo S, Makkawi HA,
Khashan A, Daoud A, et al: Intracellular porphyromonas gingivalis
promotes the tumorigenic behavior of pancreatic carcinoma cells.
Cancers (Basel). 12(2331)2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Alfano M, Canducci F, Nebuloni M, Clementi
M, Montorsi F and Salonia A: The interplay of extracellular matrix
and microbiome in urothelial bladder cancer. Nat Rev Urol.
13:77–90. 2016.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Parnigoni A, Moretto P, Viola M, Karousou
E, Passi A and Vigetti D: Effects of hyaluronan on breast cancer
aggressiveness. Cancers (Basel). 15(3813)2023.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Ding X, Ting NLN, Wong CC, Huang P, Jiang
L, Liu C, Lin Y, Li S, Liu Y, Xie M, et al: Bacteroides fragilis
promotes chemoresistance in colorectal cancer, and its elimination
by phage VA7 restores chemosensitivity. Cell Host Microbe.
33:941–956.e10. 2025.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Ebelt ND, Zamloot V, Zuniga E, Passi KB,
Sobocinski LJ, Young CA, Blazar BR and Manuel ER:
Collagenase-expressing salmonella targets major collagens in
pancreatic cancer leading to reductions in immunosuppressive
subsets and tumor growth. Cancers (Basel). 3(3565)2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Elkhalifa AME, Nabi SU, Shah OS, Bashir
SM, Muzaffer U, Ali SI, Wani IA, Alzerwi NAN, Elderdery AY, Alanazi
A, et al: Insight into oncogenic viral pathways as drivers of viral
cancers: Implication for effective therapy. Curr Oncol.
30:1924–1944. 2023.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Schiller JT and Lowy DR: An introduction
to virus infections and human cancer. Recent Results Cancer Res.
217:1–11. 2021.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Pešut E, Đukić A, Lulić L, Skelin J, Šimić
I, Milutin Gašperov N, Tomaić V, Sabol I and Grce M: Human
papillomaviruses-associated cancers: An update of current
knowledge. Viruses. 13(2234)2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Skelin J, Sabol I and Tomaić V: Do or Die:
HPV E5, E6 and E7 in cell death evasion. Pathogens.
11(1027)2022.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Azran I, Schavinsky-Khrapunsky Y and Aboud
M: Role of Tax protein in human T-cell leukemia virus type-I
leukemogenicity. Retrovirology. 1(20)2004.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Sides MD, Klingsberg RC, Shan B, Gordon
KA, Nguyen HT, Lin Z, Takahashi T, Flemington EK and Lasky JA: The
epstein-barr virus latent membrane protein 1 and transforming
growth factor-β1 synergistically induce epithelial-mesenchymal
transition in lung epithelial cells. Am J Respir Cell Mol Biol.
44:852–862. 2011.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Münz C: Epstein-barr virus nuclear antigen
1: From immunologically invisible to a promising T cell target. J
Exp Med. 199:1301–1304. 2004.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Yang SZ, Zhang LD, Zhang Y, Xiong Y, Zhang
YJ, Li HL, Li XW and Dong JH: HBx protein induces EMT through c-Src
activation in SMMC-7721 hepatoma cell line. Biochem Biophys Res
Commun. 382:555–560. 2009.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Wang F, Song H, Xu F, Xu J, Wang L, Yang
F, Zhu Y and Tan G: Role of hepatitis B virus non-structural
protein HBx on HBV replication, interferon signaling, and
hepatocarcinogenesis. Front Microbiol. 14(1322892)2023.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Li T, Li D, Cheng L, Wu H, Gao Z, Liu Z,
Jiang W, Gao YH, Tian F, Zhao L and Wang S: Epithelial-mesenchymal
transition induced by hepatitis C virus core protein in
cholangiocarcinoma. Ann Surg Oncol. 17:1937–1944. 2010.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Mani H, Yen JH, Hsu HJ, Chang CC and Liou
JW: Hepatitis C virus core protein: Not just a nucleocapsid
building block, but an immunity and inflammation modulator. Tzu Chi
Med J. 34:139–147. 2021.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Pérez Escriva P, Correia Tavares
Bernardino C and Letellier E: De-coding the complex role of
microbial metabolites in cancer. Cell Rep.
44(115358)2025.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Wu X, Qian S, Zhang J, Feng J, Luo K, Sun
L, Zhao L, Ran Y, Sun L, Wang J and Xu F: Lipopolysaccharide
promotes metastasis via acceleration of glycolysis by the nuclear
factor-κB/snail/hexokinase3 signaling axis in colorectal cancer.
Cancer Metab. 9(23)2021.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Li S, Xu X, Jiang M, Bi Y, Xu J and Han M:
Lipopolysaccharide induces inflammation and facilitates lung
metastasis in a breast cancer model via the prostaglandin E2-EP2
pathway. Mol Med Rep. 11:4454–4462. 2015.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Batbayar S, Lee DH and Kim HW:
Immunomodulation of fungal β-Glucan in host defense signaling by
dectin-1. Biomol Ther (Seoul). 20:433–445. 2012.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Wang H, Capula M, Krom BP, Yee D,
Giovannetti E and Deng D: Of fungi and men: Role of fungi in
pancreatic cancer carcinogenesis. Ann Transl Med.
8(1257)2020.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Ke J, Zhang CJ, Wang LZ, Xie FS, Wu HY, Li
T, Bian CW and Wu RL: Lipopolysaccharide promotes cancer cell
migration and invasion through METTL3/PI3K/AKT signaling in human
cholangiocarcinoma. Heliyon. 10(e29683)2024.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Jang JY, Seo JH, Choi JJ, Ryu HJ, Yun H,
Ha DM and Yang J: Insight into microbial extracellular vesicles as
key communication materials and their clinical implications for
lung cancer (Review). Int J Mol Med. 56:1–11. 2025.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Nguyen TT, Ung TT, Kim NH and Jung YD:
Role of bile acids in colon carcinogenesis. World J Clin Cases.
6:577–588. 2018.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Donohoe DR, Collins LB, Wali A, Bigler R,
Sun W and Bultman SJ: The Warburg effect dictates the mechanism of
butyrate-mediated histone acetylation and cell proliferation. Mol
Cell. 48:612–626. 2012.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Davies J, Mayer MJ, Juge N, Narbad A and
Sayavedra L: Bacteroides thetaiotaomicron enhances H2S production
in Bilophila wadsworthia. Gut Microbes. 16(2431644)2024.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Sustainable Development Goals (SDG 3). U N
West Eur. Goal 3: Ensure healthy lives and promote well-being for
all at all ages. https://www.un.org/sustainabledevelopment/health/.
|
|
73
|
El Khadir M, Alaoui Boukhris S, Benajah
DA, El Rhazi K, Ibrahimi SA, El M, Harmouch T, Nejjari C, Mahmoud
M, Benlemlih M and Bennani B: VacA and CagA status as biomarker of
two opposite end outcomes of helicobacter pylori infection (Gastric
Cancer and Duodenal Ulcer) in a moroccan population. PLoS One.
12(e0170616)2017.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Zuraik AA, Daboul Y, Awama MA, Yazigi H,
Kayasseh MA and Georges M: Rapid detection of FadA in Fusobacterium
nucleatum using the quantitative LAMP colorimetric phenol red
method in stool samples from colorectal cancer patients. Sci Rep.
14(13739)2024.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Yan J, Yang L, Ren Q, Zhu C, Du H, Wang Z,
Qi Y, Xian X and Chen D: Gut microbiota as a biomarker and
modulator of antitumor immunotherapy outcomes. Front Immunol.
15(1471273)2024.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Olsen I and Potempa J: Strategies for the
inhibition of gingipains for the potential treatment of
periodontitis and associated systemic diseases. J Oral Microbiol:
Aug 18, 2014 (Epub ahead of print). doi: 10.3402/jom.v6.24800.
|
|
77
|
Tsao LC, Force J and Hartman ZC:
Mechanisms of therapeutic antitumor monoclonal antibodies. Cancer
Res. 81:4641–4651. 2021.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Hibstu Z, Belew H, Akelew Y and Mengist
HM: Phage therapy: A different approach to fight bacterial
infections. Biologics. 16:173–186. 2022.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Kohli AS, Sanyal S, Kaushal RS and Dwivedi
M: An insight into immunological therapeutic approach against
cancer: Potential anticancer vaccines. Curr Genomics. 26:175–190.
2025.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Abouelela ME and Helmy YA: Next-generation
probiotics as novel therapeutics for improving human health:
Current trends and future perspectives. Microorganisms.
12(430)2024.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Anwer EKE, Ajagbe M, Sherif M, Musaibah
AS, Mahmoud S, ElBanbi A and Abdelnaser A: Gut microbiota secondary
metabolites: Key roles in GI tract cancers and infectious diseases.
Biomedicines. 13(100)2025.PubMed/NCBI View Article : Google Scholar
|
